MANNKIND CORP
For the period ended Dec 31, 2023. Filed Feb 27, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 27, 2024
MNKD$4.19+7.4%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
| December 31, 2023 | December 31, 2022 | |
|---|---|---|
| (In thousands except share and per share data) | ||
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $238,480 | $69,767 |
| Short-term investments | 56,619 | 101,079 |
| Accounts receivable, net | 14,901 | 16,801 |
| Inventory | 28,545 | 21,772 |
| Prepaid expenses and other current assets | 34,848 | 25,477 |
| Total current assets | 373,393 | 234,896 |
| Property and equipment, net | 84,220 | 45,126 |
| Goodwill | 1,931 | 2,428 |
| Other intangible asset | 1,073 | 1,153 |
| Long-term investments | 7,155 | 1,961 |
| Other assets | 7,426 | 9,718 |
| Total assets | $475,198 | $295,282 |
| LIABILITIES AND STOCKHOLDERS' DEFICIT | ||
| Current liabilities: | ||
| Accounts payable | $9,580 | $11,052 |
| Accrued expenses and other current liabilities | 42,036 | 35,553 |
| Financing liability – current | 9,809 | 9,565 |
| Midcap credit facility – current | 20,000 | — |
| Liability for sale of future royalties – current | 9,756 | — |
| Deferred revenue – current | 9,085 | 1,733 |
| Recognized loss on purchase commitments – current | 3,859 | 9,393 |
| Total current liabilities | 104,125 | 67,296 |
| Mann Group convertible note | 8,829 | 8,829 |
| Accrued interest – Mann Group convertible note | 56 | 55 |
| Financing liability – long term | 94,319 | 94,512 |
| Midcap credit facility – long term | 13,019 | 39,264 |
| Senior convertible notes | 226,851 | 225,397 |
| Liability for sale of future royalties – long term | 136,054 | — |
| Recognized loss on purchase commitments – long term | 60,942 | 62,916 |
| Operating lease liability | 3,925 | 5,343 |
| Deferred revenue – long term | 69,794 | 37,684 |
| Milestone liabilities | 3,452 | 4,524 |
| Total liabilities | 721,366 | 545,820 |
| Commitments and contingencies (Note 16) | ||
| Stockholders' deficit: | ||
| Undesignated preferred stock, $0.01 par value – 10,000,000 shares authorized; no shares issued or outstanding as of December 31, 2023 and 2022 | — | — |
| Common stock, $0.01 par value – 800,000,000 and 400,000,000 shares authorized as of December 31, 2023 and 2022, respectively, and 270,034,495 and 263,793,305 shares issued and outstanding as of December 31, 2023 and 2022, respectively | 2,700 | 2,638 |
| Additional paid-in capital | 2,980,539 | 2,964,293 |
| Accumulated deficit | (3,229,407) | (3,217,469) |
| Total stockholders' deficit | (246,168) | (250,538) |
| Total liabilities and stockholders' deficit | $475,198 | $295,282 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.